A systematic review on molar pregnancy

V. Satyanaranaya; D. R. Brahma Reddy; M. Lavanya; G. Maha Lakshmi; D. Sai Basha

Authors

V. Satyanaranaya Nalanda Institute of Pharmaceutical Sciences, Kantepudi (V), Sattenapalli (M), Guntur (Dist), AP.
D. R. Brahma Reddy Nalanda Institute of Pharmaceutical Sciences, Kantepudi (V), Sattenapalli (M), Guntur (Dist), AP.
M. Lavanya Nalanda Institute of Pharmaceutical Sciences, Kantepudi (V), Sattenapalli (M), Guntur (Dist), AP.
G. Maha Lakshmi Nalanda Institute of Pharmaceutical Sciences, Kantepudi (V), Sattenapalli (M), Guntur (Dist), AP.
D. Sai Basha Nalanda Institute of Pharmaceutical Sciences, Kantepudi (V), Sattenapalli (M), Guntur (Dist), AP.

Keywords:

Molar pregnancy, Gestational-trophoblatic disease, Human chorionic gonadotrophin, Chemotherapy

Abstract

Molar pregnancy is a non cancerous benign tumour that develops in the uterus. Molar pregnancy is the most common type of gestational trophoblatic disease. Molar pregnancies are most common in Asian countries, such as Taiwan, the Philippines and Japan, and also among Native Americans. Complete molar pregnancies are more common in teenage women and women over 45 years old. Most cases of molar pregnancy are diagnosed in the first trimester by ultrasound or as early pregnancy losses. The cure rate for molar pregnancies, including for those women requiring chemotherapy, is 99%. Trans-vaginal ultrasound, routinary dosage of beta – hcG and current approaches to chemotherapy, let most women with malignant gestational trophoblatic disease to be cured and their reproductive function preserved.